XETRA - Delayed Quote EUR
Heidelberg Pharma AG (HPHA.DE)
3.2000
+0.0800
+(2.56%)
At close: 5:36:11 PM GMT+2
Breakdown
TTM
11/30/2023
11/30/2022
11/30/2021
11/30/2020
Operating Cash Flow
-29,926.5070
-33,671.7990
-8,863.9430
-26,612.5200
-17,892.6110
Investing Cash Flow
-288.7040
5,847.9380
-597.5650
-1,401.9530
-1,289.7940
Financing Cash Flow
16,076.7130
-10,052.8690
84,000.9400
29,169.6620
14,290.4580
End Cash Position
36,536.4950
43,438.9220
81,329.4820
6,141.4510
4,982.2320
Capital Expenditure
-344.4650
-959.8540
-612.9320
-1,388.8070
-1,434.1260
Issuance of Capital Stock
22,760.7810
59.2080
79,911.6930
20,020.5390
14,446.0580
Free Cash Flow
-30,270.9720
-34,631.6530
-9,476.8750
-28,001.3270
-19,326.7370
11/30/2020 - 11/13/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
7V0.DE Darwin AG
28.20
0.00%
88Q.DE 4basebio PLC
13.00
0.00%
BIO.DE Biotest Aktiengesellschaft
42.60
0.00%
BIO3.DE Biotest Aktiengesellschaft
30.00
0.00%
NVV1.DE Novavax, Inc.
7.85
-0.53%
9VC.DE Atai Life Sciences N.V.
1.2600
-0.24%
AYJ.DE Valneva SE
2.8020
-4.04%
VX1.DE Vertex Pharmaceuticals Incorporated
386.40
+3.63%
BIOV.SW BioVersys N
34.70
0.00%
VSC.F 4SC AG
2.4800
0.00%